• Je něco špatně v tomto záznamu ?

SGIP1 is involved in regulation of emotionality, mood, and nociception and modulates in vivo signalling of cannabinoid CB1 receptors

M. Dvorakova, A. Kubik-Zahorodna, A. Straiker, R. Sedlacek, A. Hajkova, K. Mackie, J. Blahos

. 2021 ; 178 (7) : 1588-1604. [pub] 20210227

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025877

Grantová podpora
RVO 68378050 Czech Academy of Sciences
GACR 19-24172S Grant Agency of Czech Republic
CZ.1.05/2.1.00/19.0395 Ministry of Education, Youth and Sports of the Czech Republic; 'Higher quality and capacity for transgenic models'
P01 DA009158 NIDA NIH HHS - United States
LM2015040 Czech Centre for Phenogenomics

E-zdroje Online Plný text

NLK Free Medical Journals od 1968 do Před 1 rokem
Europe PubMed Central od 1968 do Před 1 rokem
Medline Complete (EBSCOhost) od 2002-01-01 do Před 1 rokem
Wiley Free Content od 1997 do Před 1 rokem

BACKGROUND AND PURPOSE: Src homology 3-domain growth factor receptor-bound 2-like endophilin interacting protein 1 (SGIP1) interacts with cannabinoid CB1 receptors. SGIP1 is abundantly and principally expressed within the nervous system. SGIP1 and CB1 receptors co-localize in axons and presynaptic boutons. SGIP1 interferes with the internalization of activated CB1 receptors in transfected heterologous cells. Consequently, the transient association of CB1 receptors with β-arrestin2 is enhanced and prolonged, and CB1 receptor-mediated ERK1/2 signalling is decreased. Because of these actions, SGIP1 may modulate affect, anxiety, pain processing, and other physiological processes controlled by the endocannabinoid system (ECS). EXPERIMENTAL APPROACH: Using a battery of behavioural tests, we investigated the consequences of SGIP1 deletion in tasks regulated by the ECS in SGIP1 constitutive knockout (SGIP1-/- ) mice. KEY RESULTS: In SGIP1-/- mice, sensorimotor gating, exploratory levels, and working memory are unaltered. SGIP1-/- mice have decreased anxiety-like behaviours. Fear extinction to tone is facilitated in SGIP1-/- females. Several cannabinoid tetrad behaviours are altered in the absence of SGIP1. SGIP1-/- males exhibit abnormal behaviours on Δ9 -tetrahydrocannabinol withdrawal. SGIP1 deletion also reduces acute nociception, and SGIP1-/- mice are more sensitive to analgesics. CONCLUSION AND IMPLICATIONS: SGIP1 was detected as a novel protein associated with CB1 receptors, and profoundly modified CB1 receptor signalling. Genetic deletion of SGIP1 particularly affected behavioural tests of mood-related assessment and the cannabinoid tetrad. SGIP1-/- mice exhibit decreased nociception and augmented responses to CB1 receptor agonists and morphine. These in vivo findings suggest that SGIP1 is a novel modulator of CB1 receptor-mediated behaviour.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025877
003      
CZ-PrNML
005      
20211026133424.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bph.15383 $2 doi
035    __
$a (PubMed)33491188
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Dvorakova, Michaela $u Department of Molecular Pharmacology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, Czech Republic $u Department of Psychological and Brain Sciences, Gill Center for Molecular Bioscience, Indiana University, Bloomington, Indiana, USA
245    10
$a SGIP1 is involved in regulation of emotionality, mood, and nociception and modulates in vivo signalling of cannabinoid CB1 receptors / $c M. Dvorakova, A. Kubik-Zahorodna, A. Straiker, R. Sedlacek, A. Hajkova, K. Mackie, J. Blahos
520    9_
$a BACKGROUND AND PURPOSE: Src homology 3-domain growth factor receptor-bound 2-like endophilin interacting protein 1 (SGIP1) interacts with cannabinoid CB1 receptors. SGIP1 is abundantly and principally expressed within the nervous system. SGIP1 and CB1 receptors co-localize in axons and presynaptic boutons. SGIP1 interferes with the internalization of activated CB1 receptors in transfected heterologous cells. Consequently, the transient association of CB1 receptors with β-arrestin2 is enhanced and prolonged, and CB1 receptor-mediated ERK1/2 signalling is decreased. Because of these actions, SGIP1 may modulate affect, anxiety, pain processing, and other physiological processes controlled by the endocannabinoid system (ECS). EXPERIMENTAL APPROACH: Using a battery of behavioural tests, we investigated the consequences of SGIP1 deletion in tasks regulated by the ECS in SGIP1 constitutive knockout (SGIP1-/- ) mice. KEY RESULTS: In SGIP1-/- mice, sensorimotor gating, exploratory levels, and working memory are unaltered. SGIP1-/- mice have decreased anxiety-like behaviours. Fear extinction to tone is facilitated in SGIP1-/- females. Several cannabinoid tetrad behaviours are altered in the absence of SGIP1. SGIP1-/- males exhibit abnormal behaviours on Δ9 -tetrahydrocannabinol withdrawal. SGIP1 deletion also reduces acute nociception, and SGIP1-/- mice are more sensitive to analgesics. CONCLUSION AND IMPLICATIONS: SGIP1 was detected as a novel protein associated with CB1 receptors, and profoundly modified CB1 receptor signalling. Genetic deletion of SGIP1 particularly affected behavioural tests of mood-related assessment and the cannabinoid tetrad. SGIP1-/- mice exhibit decreased nociception and augmented responses to CB1 receptor agonists and morphine. These in vivo findings suggest that SGIP1 is a novel modulator of CB1 receptor-mediated behaviour.
650    _2
$a adaptorové proteiny signální transdukční $x fyziologie $7 D048868
650    _2
$a afekt $7 D000339
650    _2
$a zvířata $7 D000818
650    _2
$a kanabinoidy $7 D002186
650    _2
$a emoce $7 D004644
650    _2
$a extinkce (psychologie) $7 D005108
650    _2
$a strach $7 D005239
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    12
$a nocicepce $7 D059225
650    12
$a receptor kanabinoidní CB1 $x genetika $7 D043884
650    _2
$a receptory kanabinoidní $7 D043882
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kubik-Zahorodna, Agnieszka $u The Czech Center for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Straiker, Alex $u Department of Psychological and Brain Sciences, Gill Center for Molecular Bioscience, Indiana University, Bloomington, Indiana, USA
700    1_
$a Sedlacek, Radislav $u The Czech Center for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Hajkova, Alena $u Department of Molecular Pharmacology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, Czech Republic
700    1_
$a Mackie, Ken $u Department of Psychological and Brain Sciences, Gill Center for Molecular Bioscience, Indiana University, Bloomington, Indiana, USA
700    1_
$a Blahos, Jaroslav $u Department of Molecular Pharmacology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, Czech Republic
773    0_
$w MED00009383 $t British journal of pharmacology $x 1476-5381 $g Roč. 178, č. 7 (2021), s. 1588-1604
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33491188 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133430 $b ABA008
999    __
$a ok $b bmc $g 1714780 $s 1146384
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 178 $c 7 $d 1588-1604 $e 20210227 $i 1476-5381 $m British journal of pharmacology $n Br J Pharmacol $x MED00009383
GRA    __
$a RVO 68378050 $p Czech Academy of Sciences
GRA    __
$a GACR 19-24172S $p Grant Agency of Czech Republic
GRA    __
$a CZ.1.05/2.1.00/19.0395 $p Ministry of Education, Youth and Sports of the Czech Republic; 'Higher quality and capacity for transgenic models'
GRA    __
$a P01 DA009158 $p NIDA NIH HHS $2 United States
GRA    __
$a LM2015040 $p Czech Centre for Phenogenomics
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...